Kratom, a tropical evergreen native to Southeast Asia, has emerged in the United States as a debated alternative to opioid medications. Known scientifically as Mitragyna speciosa, the plant’s primary active compound, mitragynine, acts on opioid receptors and may help ease withdrawal symptoms from narcotics. However, U.S. agencies like the FDA and DEA remain cautious, citing potential for addiction and lack of clinical trials confirming safety or efficacy. Despite an attempted DEA ban in 2016, strong public pushback left kratom’s legal status in limbo. Available widely online and in shops, kratom products vary in potency and purity, leaving users to navigate uncertain risks.
Read the full article at Clinical Advisor.
Kratom: A Controversial Alternative to Opioids
